Matthew Tan - CiteReady

Matthew Tan

5 of 51 articles - Show All

SAMPLE OF MY PUBLICATIONS

Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.

South Jun , Volume 89 , Issue 6 (1996)

Tal A , Graves L , Med J
El Denosumab for management of parathyroid carcinoma-mediated hypercalcemia.

Endocrinol Metab Feb doi 101210jc3031 Epub Oct 31 , Volume 99 , Issue 2 (2013)

Vellanki P , Lange K , Elaraj D , Kopp P , Muayed M , J
ckert JC, Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy.

Endocrinol Diabetes Metab Case Rep 150082 doi 101530EDM Epub Oct 29 , Volume 2015 (2015)

Jumpertz R , von Schwartzenberg R , Elbelt U , Strasburger C , Ventz M , Mai K , Kienitz T , Maurer L , Rose T , Spranger J
The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism: An Observational Study.

Ann Intern Med Jun 7 doi 107326M151232 Epub Apr 5 , Volume 164 , Issue 11 (2016)

Yeh M , Zhou H , Adams A , Ituarte P , Li N , Liu I , Haigh P
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.

Endocrinol Metab , Volume 96 (2011)

Peacock M , Bilezikian J , Bolognese M , J

0 of 0 collections - Show All

(No collections found)